Medimage
ActiveMedimage has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €100 and a net result of €192k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 16408 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
70
/ 100
Healthy▼ -30 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency33▼-67
Growth58▼-20
Stability94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity ample (current ratio 54.63 against 8.25 in 2024), but 100% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
0%
Return on assets
30.4%
Age of the figures
8 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 16408 sector peers (2025).
NBB · sector comparisonPosition among 16408 sector peers
Solvency
better than 5%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-04-2026, 113 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
113 d early
2024
41 d early
2023
30 d early
2022
2 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
14-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€100▼ 100.0%
2024 · €497k
2022: €118k
2023: €298k
2024: €497k
2022 → 2025
Total assets
€632k▲ 11.8%
2024 · €565k
2022: €160k
2023: €354k
2024: €565k
2022 → 2025
Net result
€192k▼ 3.5%
2024 · €199k
2022: €118k
2023: €179k
2024: €199k
2022 → 2025
Working capital
€621k▲ 25.1%
2024 · €496k
2022: €117k
2023: €297k
2024: €496k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€118k-€298k▲ 152%€497k▲ 66.8%€100▼ 100.0%
Operating result€152k-€235k▲ 54.5%€262k▲ 11.3%€251k▼ 4.0%
Net result€118k-€179k▲ 51.9%€199k▲ 10.9%€192k▼ 3.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 4% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €632k
Equity
€100▼ 100.0%
Debt
€632k▲ 823%
The debt ratio rises from 12.1% to 100.0%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€252k▼
2024 · €262k
Cash flow
€193k▼
2024 · €200k
Solvency
0.0%▼
2024 · 87.9%
Current ratio
54.63▲
2024 · 8.25
Quick ratio
54.63▲
2024 · 8.25
ROA
30.4%▼
2024 · 35.2%
Interest coverage
2767.92▼
2024 · 3237.52
Debt
€632k▲
2024 · €68k
Debt ≤ 1 year
€12k▼
2024 · €68k
Debt > 1 year
€620k
Income taxes
€60k▼
2024 · €63k
Equity ratios withheld: equity of €100 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€565k€632k▲
Fixed assets21/28€525-
Tangible fixed assets22/27€525-
Furniture and vehicles24€525-
Current assets29/58€565k€632k▲
Cash at bank and in hand54/58€449k€522k▲
Deferred charges and accrued income490/1€116k€110k▼
Equity and liabilities
Total equity and liabilities10/49€565k€632k▲
Equity10/15€497k€100▼
Contributions10/11€100€100=
Reserves13€497k-
Distributable reserves133€497k-
Amounts payable17/49€68k€632k▲
Amounts payable after more than one year17-€620k
Other amounts payable178/9-€620k
Amounts payable within one year42/48€68k€12k▼
Taxes, remuneration and social security45€65k€12k▼
Taxes450/3€65k€12k▼
Other amounts payable47/48€3k-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€616€525▼
Other operating charges640/8€326€465▲
Gross operating margin9900€263k€252k▼
Operating profit (loss)9901€262k€251k▼
Financial income75/76B-€793
Recurring financial income75-€793
Financial charges65/66B€81€91▲
Recurring financial charges65€81€91▲
Profit (loss) for the period before taxes9903€262k€252k▼
Income taxes67/77€63k€60k▼
Profit (loss) for the period9904€199k€192k▼
Profit (loss) for the period to be appropriated9905€199k€192k▼
Appropriation of the result
Profit (loss) to be appropriated9906€199k€192k▼
Transfer from equity791/2-€497k
Transfer to equity691/2€199k-
To other reserves6921€199k-
Profit to be distributed694/7-€689k
Return on contributions (dividend)694-€689k
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity times 7current ratio 54.63
Current ratio from 8.25 to 54.63; short-term debt falls from €68k to €12k.
20-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €199k ▲10.9%
Operating result €262k, net result €199k, both a record.
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €200kEq €298k ▲152%
2 profitable years in a row build equity to €298k.
29-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bierbeek · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Pimberg 1093360 BierbeekGround area
868 m²
Building footprint
87 m²
Volume, LiDAR
798 m³
Parcel 24053B0137/00F000, Flanders · tallest building 11.0 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Pimberg 109, 3360 Bierbeek
since 20222.329.314.151
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24053B0137/00F000 | Flanders | 868 m² | 1 · 87 m² | 11.0 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Have A Nice Day Surgery
BE 0541.758.757
Lubbeek · Eq €100
Dr. V. Vervaet
BE 0558.908.357
Destelbergen · Eq €100
Dr. Kurt Buccauw, radiologie
BE 0644.845.607
Oud-Heverlee · Eq €100
DRS. CAEKEBEKE EN D'HAESE
BE 0649.939.095
Kortrijk · Eq €100
Dokter Mestdagh Martine, dermatologie
BE 0653.991.222
Lokeren · Eq €100
Of 16,601 companies in sector 86220 we hold annual accounts for 7,960. 97 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded16-03-2022
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
77225Rental and leasing activities
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.